<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        160-172-06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        GLORION 3MG TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        GLIMEPIRIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        26
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Hikma Pharmaceuticals PLC" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Hikma Pharmaceuticals PLC
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Hikma Pharmaceuticals PLC
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A10BB12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>GLORION is a medicine taken &nbsp;by mouth to help lower blood sugar. It belongs to a group of medicines called sulfonylureas.</p><p>GLORION works by increasing the amount of insulin released from your pancreas. The insulin then lowers your blood sugar levels.</p><p>GLORION is used to treat a certain &nbsp;form of diabetes (type 2 diabetes mellitus) when diet, physical &nbsp;exercise and weight reduction alone &nbsp;have &nbsp;not been able to control your blood sugar levels.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take GLORION</strong></p><p>Do not take GLORION and tell your doctor if<strong>:</strong></p><ul><li>You are allergic (hypersensitive) to: Glimepiride or other sulfonylureas (medicines used to lower your blood sugar such &nbsp;as glibenclamide) or sulfonamides (medicines for bacterial infections &nbsp;such &nbsp;as sulfamethoxazole) or any of the other ingredients of GLORION.</li><li>You have &nbsp;insulin dependent diabetes (type 1 diabetes mellitus).</li><li>You have &nbsp;diabetic &nbsp;ketoacidosis (a complication of diabetes when your acid level is raised in your body and you may have &nbsp;some of the following signs: fatigue, &nbsp;feeling sick (Nausea), frequent urination and muscular stiffness).</li><li>You are in a diabetic &nbsp;coma.</li><li>You have &nbsp;severe kidney disease.</li><li>You have &nbsp;a severe liver disease.</li></ul><p>Do not take this medicine if any of the above applies to you.</p><p>If you are not sure, talk to your doctor or pharmacist before &nbsp;taking GLORION.</p><p><strong>T</strong><strong>ake special care with GLORION</strong></p><p><strong>Check &nbsp;with your doctor or pharmacist before taking your medicine if:</strong></p><ul><li>You are recovering from an injury, operation, infections &nbsp;with fever, or from other forms of stress, inform your doctor as temporary change of treatment may be necessary.</li><li>You have &nbsp;a severe liver or kidney disorder.</li></ul><p>If you are not sure &nbsp;if any of these apply to you, talk to your doctor or pharmacist before &nbsp;taking GLORION. Lowering of the haemoglobin level and breakdown of red blood cells (haemolytic anemia) can occur in patients missing &nbsp;the enzyme glucose-6-phosphate dehydrogenase.</p><p>The information available on the use &nbsp;of GLORION in people under &nbsp;18 years of age &nbsp;is limited. Therefore, its use &nbsp;in these patients is not recommended.</p><p><strong>Important information about &nbsp;hypoglycaemia (low blood sugar).</strong></p><p>When you take GLORION, you may get hypoglycaemia (low blood sugar). Please see below for additional information about &nbsp;hypoglycaemia, its signs &nbsp;and treatment.</p><p><strong>Following factors could increase </strong><strong>the risk of you getting hypoglycaemia:</strong></p><ul><li>Undernourishment, irregular meal time, missed or delayed meal or period of fasting.</li><li>Changes to your diet.</li><li>Taking more GLORION than needed.</li><li>Having kidneys &nbsp;that do not work properly.</li><li>Having severe liver disease.</li><li>If you suffer from particular &nbsp;hormone-induced disorders (disorders of the thyroid glands, of the pituitary gland or adrenal cortex).</li><li>Drinking alcohol (especially when you skip a meal).</li><li>Taking certain &nbsp;other medicines (See Taking other medicines, herbal &nbsp;or dietary supplements below).</li><li>If you increase the amount of exercise you do and you don&rsquo;t eat enough food or eat food containing &nbsp;less carbohydrate than usual.</li></ul><p><strong>Signs </strong><strong>of hypoglycaemia include:</strong></p><ul><li>Hunger &nbsp;pangs, headache, nausea, vomiting, sluggishness, sleepiness, problems sleeping, restlessness, aggression, problems with concentration, reduced alertness and reaction time, depression, confusion, problems with your speech and sight, slurred &nbsp;speech, shakiness, partial paralysis, dizziness, helplessness.</li><li>The following signs &nbsp;may also occur: sweating, clammy skin, anxiety, &nbsp;fast or increased heart &nbsp;beat, high blood pressure, awareness of your heart &nbsp;beat, sudden strong &nbsp;pain in the breast that may radiate into neighbouring areas (angina pectoris and cardiac arrhythmias). If blood sugar levels continue to drop you may suffer from considerable confusion (delirium), develop fits, lose self control, breathing may be shallow and your heart &nbsp;beat slowed &nbsp;down, you may fall into unconsciousness. The clinical picture of a severe reduced blood sugar level may resemble that of a stroke.</li></ul><p><strong>T</strong><strong>reating hypoglycaemia:</strong></p><p>In most cases the signs &nbsp;of reduced blood sugar vanish &nbsp;very quickly when you consume some form of sugar, e.g. sugar cubes, sweet juice, sweetened tea.&nbsp; You should &nbsp;therefore always &nbsp;take some form of sugar with you (e.g. sugar cubes). Remember that artificial sweeteners are not effective. &nbsp;Please contact your doctor or go to the hospital &nbsp;if taking sugar does not help or if the symptoms recur.</p><p><strong>Laboratory &nbsp;Tests</strong></p><p>The level of sugar in your blood or urine should &nbsp;be checked regularly. &nbsp;Your doctor may also take blood tests to monitor your blood cell levels and liver function.</p><p><strong>T</strong><strong>aking other medicines, herbal or dietary supplements</strong></p><p>Please tell your doctor or pharmacist if you are taking or have &nbsp;recently &nbsp;taken &nbsp;any other medicines, including medicines obtained without a prescription.</p><p>Your doctor may wish to change your dose of GLORION if you are taking other medicines, which may weaken or strengthen the effect of GLORION on the level of sugar in your blood.</p><p><strong>The following medicines can increase the blood sugar lowering effect of GLORION. This can lead to a risk of hypoglycaemia (low blood sugar):</strong></p><ul><li>Other medicines to treat diabetes mellitus (such &nbsp;as insulin or metformin).</li><li>Medicines to treat pain and inflammation &nbsp;(phenylbutazone, azopropazone, oxyphenbutazone, aspirin-like medicines).</li><li>Medicines to treat urinary infections &nbsp;(such &nbsp;as some long acting sulfonamides).</li><li>Medicines to treat bacterial and fungal infections &nbsp;(Tetracyclines, chloramphenicol, fluconazole, miconazole, quinolones, clarithromycin).</li><li>Medicines to inhibit blood clotting (coumarin derivatives such &nbsp;as warfarin).</li><li>Medicines supporting muscle build up (anabolics).</li><li>Medicines used for male sex hormone replacement therapy.</li><li>Medicines to treat depression (fluoxetine, &nbsp;MAOinhibitors).</li><li>Medicines lowering high cholesterol level (fibrates).</li><li>Medicines lowering high blood pressure (ACE inhibitors).</li><li>Medicines called anti-arrhythmic agents used to control abnormal heart &nbsp;beat &nbsp;(disopyramide).</li><li>Medicines to treat gout (allopurinol, probenecid, sulfinpyrazone).</li><li>Medicines to treat cancer (cyclophosphamide, ifosfamide, &nbsp;trofosfamide).</li><li>Medicines used to reduce weight (fenfluramine).</li><li>Medicines to increase circulation when given in a high dose intravenous infusion (pentoxifylline).</li><li>Medicines to treat nasal allergies such &nbsp;as hay fever (tritoqualine).</li><li>Medicines called sympatholytics to treat high blood pressure, heart &nbsp;failure, or prostate symptoms.</li></ul><p><strong>The following medicines may decrease the blood sugar lowering effect of GLORION. This can lead to a risk of hyperglycaemia (high blood sugar level):</strong></p><ul><li>Medicines containing &nbsp;female &nbsp;sex hormones (oestrogens, progestogens).</li><li>Medicines to treat high blood pressure called thiazide &nbsp;diuretics &nbsp;(water tablets).</li><li>Medicines used to stimulate the thyroid gland (such &nbsp;as levothyroxine).</li><li>Medicines to treat allergies and inflammation &nbsp;(glucocorticoids).</li><li>Medicines to treat severe mental &nbsp;disorders (chlorpromazine and other phenothiazine derivatives).</li><li>Medicines used to raise &nbsp;heart &nbsp;beat, to treat asthma or nasal congestion, coughs and colds, &nbsp;used to reduce weight, or used in life-threatening emergencies (adrenaline and sympathomimetics).</li><li>Medicines to treat high cholesterol level (nicotinic acid).</li><li>Medicines to treat constipation when they are used long term (laxatives).</li><li>Medicines to treat fits (phenytoin).</li><li>Medicines to treat nervousness and sleep problems (barbiturates).</li><li>Medicines to treat increased pressure in the eye (azetazolamide).</li><li>Medicines to treat high blood pressure or lowering blood sugar (diazoxide).</li><li>Medicines to treat infections, &nbsp;tuberculosis (rifampicine).</li><li>Medicines to treat severe low blood sugar levels (glucagon).</li></ul><p><strong>The following medicines can increase or decrease the blood sugar lowering effect of GLORION:</strong></p><ul><li>Medicines to treat stomach ulcers &nbsp;(called H2 antagonists).</li><li>Medicines to treat high blood pressure or heart &nbsp;failure such &nbsp;as beta-blockers, clonidine, &nbsp;guanethidine and reserpine. These can also hide the signs &nbsp;of hypoglycaemia, so special care &nbsp;is needed when taking these medicines.</li></ul><p><strong>GLORION </strong><strong>may either increase or weaken the effects of the following medicines:</strong></p><ul><li>Medicines inhibiting blood clotting (coumarin derivatives such &nbsp;as warfarin).</li></ul><p><strong>T</strong><strong>aking GLORION with food &nbsp;and drink</strong></p><p>Alcohol intake may increase or decrease the blood sugar lowering action of GLORION in an unpredictable way.</p><p><strong>Pregnancy </strong><strong>and breast feeding</strong></p><p><strong>Pregnancy</strong></p><p>GLORION should &nbsp;not be taken &nbsp;during pregnancy. Tell your doctor if you are, &nbsp;you think you might be or are planning to become pregnant.</p><p><strong>Breast feeding</strong></p><p>GLORION may pass into breast milk. GLORION should &nbsp;not be taken &nbsp;during breast feeding.</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Driving and using machines</strong></p><p>Your ability to concentrate or react &nbsp;may be reduced if your blood sugar is lowered &nbsp;(hypoglycaemia), or raised (hyperglycaemia) or if you develop visual problems as a result of such &nbsp;conditions. Bear in mind that you could endanger yourself or others (e.g. when driving a car or using machines). Please ask your doctor whether you can drive a car if you:</p><ul><li>Have frequent episodes of hypoglycaemia.</li><li>Have fewer or no warning signals of hypoglycaemia.</li></ul><p><strong>Important information about &nbsp;some of the ingredients of GLORION</strong></p><p>GLORION contains lactose. If you have &nbsp;been told by your doctor that you cannot tolerate some sugars, contact your doctor before &nbsp;taking this medicinal &nbsp;product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You should check with your doctor or pharmacist if you are not sure.</p><p><strong>T</strong><strong>aking this medicine</strong></p><p>Take this medicine by mouth, just before &nbsp;or with the first main meal of the day (usually breakfast). If you do not have breakfast you should &nbsp;take the product &nbsp;on schedule as prescribed by your doctor. &nbsp;It is important &nbsp;not to leave &nbsp;out any meal when you are on GLORION.</p><p>Swallow the tablets whole with at least &nbsp;half glass of water. &nbsp;Do not crush &nbsp;or chew the tablets.</p><p><strong>How much &nbsp;to take</strong></p><p>The dose of GLORION depends on your needs, condition and results of blood and urine sugar tests and is determined by your doctor. &nbsp;Do not take more tablets than your doctor has &nbsp;prescribed.</p><p>The usual &nbsp;starting &nbsp;dose is one GLORION 1 mg tablet once &nbsp;a day.</p><p>If necessary, your doctor may increase the dose after each 1 - 2 weeks of treatment.</p><p>The maximum &nbsp;recommended dose is 6 mg glimepiride per day.</p><p>A combination therapy of glimepiride plus metformin or of glimepiride plus insulin may be started. In such &nbsp;a case your doctor will determine the proper &nbsp;doses of glimepiride, &nbsp;metformin or insulin individually for you.</p><p>Your dose of GLORION may need to be adjusted if you change weight, change your lifestyle, or if you are under &nbsp;a lot of stress. Please speak to your doctor if any of these situations apply to you.</p><p>If you feel the effect of your medicine is too weak or too strong &nbsp;do not change the dose yourself, &nbsp;but ask your doctor.</p><p><strong>If you take more GLORION than you should</strong></p><p>If you happen to have &nbsp;taken &nbsp;too much GLORION or an additional &nbsp;dose there &nbsp;is a danger of hypoglycaemia (signs of hypoglycaemia see Section 2 - Take special care &nbsp;with GLORION) and therefore you should &nbsp;instantly consume enough sugar (e.g. a small bar of sugar cubes, sweet juice, sweetened tea) and inform a doctor immediately.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>When treating &nbsp;hypoglycaemia due to accidental intake in children, &nbsp;the quantity of sugar given must be carefully controlled &nbsp;to avoid the possibility of producing dangerous hyperglycaemia. Persons in a state of unconsciousness must not be given food or drink.</p><p>Since the state of hypoglycaemia may last for some time it is very important that the patient is carefully monitored until there &nbsp;is no more danger. Admission &nbsp;into hospital &nbsp;may be necessary, also as a measure of precaution. Show the doctor the package or remaining tablets, so the doctor knows what has &nbsp;been taken.</p><p>Severe cases of hypoglycaemia accompanied by loss of consciousness and coma &nbsp;are cases of medical &nbsp;emergency requiring immediate medical &nbsp;treatment and admission into hospital. &nbsp;It may be helpful to tell your family and friends to call a doctor immediately &nbsp;if this happens to you.</p><p><strong>If you forget &nbsp;to take GLORION</strong></p><p>If you forget to take a dose, do not take a double &nbsp;dose to make &nbsp;up for forgotten &nbsp;doses.</p><p><strong>If you stop taking GLORION</strong></p><p>If you interrupt or stop the treatment you should &nbsp;be aware that the desired blood sugar lowering effect is not achieved or that the disease will get worse &nbsp;again. &nbsp;Keep taking GLORION until your doctor tells you to stop.</p><p><strong>If you have &nbsp;any further questions on the use of this product, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, GLORION can cause side effects, &nbsp;although not everybody gets &nbsp;them.</p><p><strong>T</strong><strong>ell your doctor immediately if you experience any of the following symptoms:</strong></p><ul><li>Allergic reactions (including inflammation &nbsp;of blood vessels, often with skin rash) &nbsp;which may develop into serious reactions with difficulty in breathing, fall in blood pressure and sometimes progressing to shock.</li><li>Abnormal liver function including yellowing of the skin and eyes (jaundice), problems with the bile flow (cholestasis), inflammation &nbsp;of the liver (hepatitis) or liver failure.</li><li>Allergy (hypersensitivity) of the skin such &nbsp;as itching, rash, hives and increased sensitivity to sun.</li><li>Some mild allergic reactions may develop into serious reactions.</li><li>Severe hypoglycaemia including loss of consciousness, seizures or coma.</li></ul><p><strong>Some patients experienced </strong><strong>the following side effects whilst &nbsp;taking GLORION: </strong></p><p><strong>Rare side effects (affects 1 to 10 patients in 10,000):</strong></p><ul><li>Lower blood sugar than normal (hypoglycaemia).</li><li>Decrease in the number of blood cells:</li><li>Blood platelets (which increases risk of bleeding or bruising).</li><li>White blood cells (which makes infections &nbsp;more likely).</li><li>Red blood cells (which can make &nbsp;the skin pale and cause weakness or breathlessness).</li></ul><p>These problems generally get better &nbsp;after you stop taking GLORION.</p><p><strong>V</strong><strong>ery rare side effects (affects less than 1 patient &nbsp;in 10,000):</strong></p><ul><li>Allergic reactions (including inflammation &nbsp;of blood vessels, often with skin rash) &nbsp;which may develop into serious reactions with difficulty in breathing, fall in blood pressure and sometimes progressing to shock. &nbsp;If you experience any of these symptoms, tell your doctor immediately.</li><li>Abnormal liver function including yellowing of the skin and eyes (jaundice), impairment of the bile flow (cholestasis), inflammation &nbsp;of the liver (hepatitis) or liver failure. If you experience any of these symptoms, tell your doctor immediately.</li><li>Feeling &nbsp;or being sick, diarrhoea, feeling full or bloated, and abdominal pain.</li><li>Decrease in the amount of sodium &nbsp;level in your blood (shown &nbsp;by blood tests).</li></ul><p><strong>Other side effects include:</strong></p><ul><li>Allergy (hypersensitivity) of the skin may occur such &nbsp;as itching, rash, hives and increased sensitivity to sun. &nbsp;Some mild allergic reactions may develop into serious reactions with swallowing or breathing problems, swelling of your lips, throat or tongue. Therefore in the event &nbsp;of one of these side effects, &nbsp;tell your doctor immediately.</li><li>Allergic reactions with sulfonylureas, sulfonamides, or related drugs &nbsp;may occur.</li><li>Problems with your sight may occur when beginning treatment with GLORION. This is due to changes in blood sugar levels and should &nbsp;soon &nbsp;improve.</li><li>Increased liver enzymes.</li></ul><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, &nbsp;please tell your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>Keep out of the reach and sight of children.</li><li>Do not use &nbsp;GLORION after the expiry date &nbsp;which is stated after &lsquo;EXP&rsquo; on the blister and carton. The expiry date refers &nbsp;to the last day of that month.</li><li>Do not store &nbsp;above 30&deg;C.</li><li>Store &nbsp;in the original package in order to protect &nbsp;from moisture.</li><li>Do not use &nbsp;GLORION if you notice visible signs &nbsp;of deterioration.</li><li>Medicines should &nbsp;not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect &nbsp;the environment.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is glimepiride. &nbsp;Each &nbsp;tablet contains 1 mg, 2 mg, 3 mg or 4 mg glimepiride depending on the strength indicated on the blister and carton.</p><p>The other ingredients are lactose monohydrate, sodium &nbsp;starch glycolate, &nbsp;magnesium stearate, microcrystalline cellulose and sodium &nbsp;lauryl sulfate.</p><p>In addition the tablets contain colouring agents:</p><ul><li>1 mg tablets contain&nbsp;red iron oxide.</li><li>2 mg tablets contain&nbsp;yellow iron oxide and 12196 &nbsp;FD &amp; C blue lake no. 2.</li><li>3 mg tablets contain&nbsp;yellow iron oxide.</li><li>4 mg tablets contain 12196 &nbsp;FD &amp; C blue lake no. 2.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Each  strength of GLORION is small bisected capsule shape tablets. They are different in colour and engraving:
•    1 mg tablets are pink, engraved with H85.
•    2 mg tablets are green, engraved with H84.
•    3 mg tablets are yellow, engraved with H83.
•    4 mg tablets are blue, engraved with H82.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder and Manufacturer</strong></p><p>Hikma Pharmaceuticals</p><p>Bayader Wadi El Seer, Industrial Area</p><p>P.O Box 182400 Amman 11118, Jordan</p><p>Tel: +962 6 580 2900</p><p>Fax: +962 6 581 7102</p><p>Website: www.Hikma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet  was  last approved in 11/2013; version number  v1.1. 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="direction: rtl;">چلوريون هو دواء يُؤخذ عن طريق الفم ليساعد على تخفيض السكر في الدم، ينتمي إلى المجموعة الدوائية التي تدعى السلفونيل يوريا.يعمل چلوريون على زيادة كمية الإنسولين المفرزة من البنكرياس. حيث يخفض الإنسولين مستويات السكر في الدم. يستعمل چلوريون لمعالجة نوع معين من السكري (النوع 2 من داء السكري) عندما لا يكون النظام الغذائي، التمارين البدنية وتخفيض الوزن بمفردها قادرة على السيطرة على مستويات السكر في الدم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;"><strong>موانع إستعمال چلوريون:</strong></p><p style="direction: rtl;">لا تستخدم چلوريون وأخبر طبيبك:</p><ul><li style="direction: rtl;">إذا كنت تعاني من حساسية (فرط حساسية) لچليمبيرايد أو غيره من السلفونيل يوريا (أدوية تستخدم لتخفيض السكر في الدم مثل الغليبينكلاميد) أو السلفوناميدات (أدوية للعدوات البكتيرية مثل السلفاميثوكسازول) أو أي من المواد الأخرى المستخدمة في تركيبة چلوريون.</li><li style="direction: rtl;">إذا كنت تعاني من السكري المعتمد على الإنسولين (النوع 1 من داء السكري).</li><li style="direction: rtl;">إذا كنت تعاني من الحماض الكيتوني السكري (من مضاعفات السكري عندما يرتفع مستوى الحمض في جسمك وقد يكون لديك بعض من العلامات&nbsp;التالية: التعب، الشعور بالإعياء (الغثيان)، كثرة التبول وتصلب العضلات).</li><li style="direction: rtl;">إذا كنت في غيبوبة السكري.</li><li style="direction: rtl;">إذا كنت تعاني من مرض شديد في الكلى.</li><li style="direction: rtl;">إذا كنت تعاني من مرض شديد في الكبد.</li></ul><p style="direction: rtl;">لا تتناول هذا الدواء إذا كان أي من الوارد أعلاه ينطبق عليك.</p><p style="direction: rtl;">إذا كنت غير متأكداً، راجع طبيبك أو الصيدلي قبل تناول چلوريون.</p><p style="direction: rtl;"><strong>الاحتياطات عند استخدام چلوريون:</strong></p><p style="direction: rtl;"><strong>تحقق من طبيبك أو الصيدلي قبل إستخدام الدواء إذا:</strong></p><ul><li style="direction: rtl;">كنت تتعافى من إصابة، عملية، عدوى مع حمى أو انواع أخرى من الإجهاد، أخبر طبيبك حيث قد يكون التغيير المؤقت للعلاج ضرورياً.</li><li style="direction: rtl;">كان لديك إضطراب شديد في الكبد أو الكلى.</li></ul><p style="direction: rtl;">إذا كنت غير متاكداً أن ما ورد ينطبق عليك، راجع طبيبك أو الصيدلي قبل تناول چلوريون.</p><p style="direction: rtl;">قد يحدث إنخفاض في مستوى الهيموجلوبين وهبوط في خلايا الدم الحمراء (فقر الدم الإنحلالي) للمريض الفاقد لإنزيم نازعة هيدروجين الغلوكوز-6 فوسفات.</p><p style="direction: rtl;">المعلومات المتوفرة عن إستخدام چلوريون للأشخاص الذين تقل أعمارهم عن 18 عاماً محدودة. لذلك لا يوصى بإستخدامه لهؤلاء المرضى.</p><p style="direction: rtl;"><strong>معلومات هامة عن نقص سكر الدم (إنخفاض السكر في الدم). </strong></p><p style="direction: rtl;">عندما تتناول چلوريون قد يحدث لديك نقص سكر الدم (إنخفاض السكر في الدم). يرجى مراجعة ما يلي لمزيد من المعلومات عن نقص سكر الدم، علاماته وعلاجه.</p><p style="direction: rtl;"><strong>قد تزيد العوامل التالية من خطر حدوث نقص سكر الدم لديك:</strong></p><ul><li style="direction: rtl;">سوء التغذية، عدم إنتظام وقت وجبات الطعام، غياب أو تأخير الوجبة أو فترة الصيام.</li><li style="direction: rtl;">التغيرات في نظامك الغذائي.</li><li style="direction: rtl;">تناول ما يزيد عن حاجتك من چلوريون.</li><li style="direction: rtl;">ان تكون الكلى لديك لا تعمل بشكل سليم.</li><li style="direction: rtl;">إن كنت تعاني من مرض شديد في الكبد.</li><li style="direction: rtl;">إن كنت تعاني من إضطرابات ناجمة عن هرمون معين (إضطرابات في الغدد الدرقية، من الغدة النخامية أو قشرة الكظرية).</li><li style="direction: rtl;">شرب الكحول (خاصة عندما تتخطى وجبة طعام).&nbsp;</li><li style="direction: rtl;">تناول أدوية أخرى معينة (أنظر التداخلات الدوائية مع الأدوية الأخرى أو الأعشاب أوالمكملات الغذائية أدناه).</li><li style="direction: rtl;">إذا قمت بزيادة التمرينات التي تمارسها ولا تأكل ما يكفي من الطعام أو تأكل طعام يحتوي على كربوهيدرات أقل من المعتاد.</li></ul><p style="direction: rtl;"><strong>علامات نقص سكر الدم تتضمن:</strong></p><ul><li style="direction: rtl;">آلام الجوع، الصداع، الغثيان، التقيؤ، الخمول، النعاس، مشاكل النوم، الأرق، العدائية، مشاكل في التركيز، إنخفاض اليقظة ووقت رد الفعل، الإكتئاب، الإرتباك، مشاكل في النطق والبصر، ثقل اللسان، الإرتعاش، الشلل الجزئي، الدوخة، العجز.</li><li style="direction: rtl;">قد تحدث أيضاً العلامات التالية: التعرق، تندي الجلد، القلق، سرعة أو زيادة نبضات القلب، إرتفاع ضغط الدم، إدراك نبضات القلب، ألم قوي مفاجيء&nbsp;في الصدر والذي قد يمتد إلى المناطق المجاورة (الذبحة الصدرية وعدم إنتظام ضربات القلب). وإذا إستمرت مستويات السكر في الدم بالإنخفاض فقد تعاني من التشوش (الهذيان)، ظهور النوبات، فقدان السيطرة على النفس وقد يضمحل التنفس وتتباطىء ضربات القلب، قد تصاب بالغيبوبة. وقد تشبه الصورة السريرية لإنخفاض مستوى السكر الشديد في الدم تلك التي في السكتة الدماغية.</li></ul><p style="direction: rtl;"><strong>معالجة نقص سكر الدم:</strong></p><p style="direction: rtl;">في معظم الحالات، تتلاشى علامات إنخفاض السكر في الدم بسرعة عندما تستهلك بعض أنواع السكر، مثل مكعبات السكر، عصير الحلو، شاي المحلى. لذلك يجب عليك ان تبقي دائماً نوع من السكر بحوزتك (مثلاً مكعبات السكر). وتذكر أن المحليات الإصطناعية غير فعالة. يرجى الإتصال بطبيبك أو الذهاب إلى المستشفى إذا كان تناول السكر لا يؤدي إلى نتيجة أو إذا كانت الأعراض تتكرر.</p><p style="direction: rtl;"><strong>الفحوصات المخبرية</strong></p><p style="direction: rtl;">يجب فحص مستوى السكر في الدم والبول بإنتظام. وقد يقوم الطبيب بإجراء فحوصات للدم لمراقبة مستويات خلايا الدم ووظيفة الكبد.</p><p style="direction: rtl;"><strong>التداخلات الدوائية مع الأدوية الأخرى أو الأعشاب أوالمكملات الغذائية</strong></p><p style="direction: rtl;">يجب إستشارة طبيبك أو الصيدلي إذا كنت تأخذ أو أخذت مؤخراً أية أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها بدون وصفة طبية.قد يرغب الطبيب بتغيير جرعة چلوريون إذا كنت تتناول أدوية اخرى، والتي قد تضعف أو تقوي مفعول چلوريون على مستوى السكر في الدم.</p><p style="direction: rtl;"><strong>قد تزيد الأدوية التالية من تأثير چلوريون على خفض نسبة السكر في الدم. وهذا قد يؤدي إلى خطر نقص سكر الدم (إنخفاض السكر في الدم):</strong></p><ul><li style="direction: rtl;">أدوية أخرى لمعالجة داء السكري (مثل الإنسولين أو الميتفورمين).</li><li style="direction: rtl;">أدوية علاج الألم والإلتهابات (الفنيل بوتازون، آزابروبازون، الأوكسيفين بوتازون، الأدوية المشابهة للأسبرين).</li><li style="direction: rtl;">أدوية علاج الإلتهابات البولية (مثل بعض السلفوناميدات طويلة المفعول).</li><li style="direction: rtl;">أدوية علاج الإلتهابات البكتيرية والفطرية (التتراسكلين، الكلورامفينيكول، الفلوكونازول، الميكونازول، الكينولون، الكلاريثروميسين).</li><li style="direction: rtl;">أدوية تثبط تجلط الدم (مشتقات الكومارين مثل الوارفارين).</li><li style="direction: rtl;">أدوية دعم بناء العضلات (الإبتنائيات).</li><li style="direction: rtl;">أدوية مستخدمة كبدائل لهرمون الجنسي الذكري.</li><li style="direction: rtl;">أدوية علاج الإكتئاب (الفلوكستين، مثبطات أكسيداز أحادي الأمين).</li><li style="direction: rtl;">أدوية خفض مستوى الكوليسترول العالي (الفايبريت).&nbsp;</li><li style="direction: rtl;">أدوية خفض إرتفاع ضغط الدم (مثبطات الأنزيم المحول للأنجيوتنسين).</li><li style="direction: rtl;">أدوية تدعى العوامل المضادة لعدم إتساق نبضات القلب والمستخدمة للسيطرة على نبضات القلب الغير طبيعية (ديسوبيراميد).</li><li style="direction: rtl;">أدوية علاج النقرس (الوبيورينول، البروبينسيد، السلفينبيرازون).</li><li style="direction: rtl;">أدوية علاج السرطان (سيكلوفوسفاميد، إفوسفاميد، التروفوسفاميد).</li><li style="direction: rtl;">أدوية مستخدمة لخفض الوزن (فينفلورامين).</li><li style="direction: rtl;">أدوية زيادة الدورة الدموية عندما تعطى جرعة عالية كتسريب في الوريد (البنتوكسيفيلين).</li><li style="direction: rtl;">أدوية علاج الحساسية الأنفية مثل حمى القش (تريتوكوالين).</li><li style="direction: rtl;">أدوية تدعى الداحضات الودية لعلاج إرتفاع ضغط الدم، فشل القلب أو اعراض البروستاتا.</li></ul><p style="direction: rtl;"><strong>قد تخفض الأدوية التالية من تأثير چلوريون على خفض نسبة السكر في الدم. هذا قد يؤدي إلى خطر فرط سكر الدم (إرتفاع السكر في الدم):</strong></p><ul><li style="direction: rtl;">أدوية تحتوي على هرمونات جنسية انثوية (الأستروجين، البروجستيرون).</li><li style="direction: rtl;">أدوية علاج إرتفاع ضغط الدم تدعى مدرات البول الثيازيدية (أقراص الماء).</li><li style="direction: rtl;">أدوية تستخدم لتحفيز الغدة الدرقية (مثل الليفوثيروكسين).</li><li style="direction: rtl;">أدوية علاج الحساسية والإلتهابات (غلوكوكوريتكويدات).</li><li style="direction: rtl;">ادوية علاج الإضطرابات النفسية الشديدة (الكلوربرومازين وغيرها من مشتقات الفينوثيازين).</li><li style="direction: rtl;">أدوية تستخدم لرفع ضربات القلب، لعلاج الربو أو إحتقان الأنف، السعال ونزلات البرد، تستخدم لخفض الوزن أو يتم إستخدامها في حالات الطوارىء التي تهدد الحياة (الأدرينالين والمحاكيات الودية).</li><li style="direction: rtl;">أدوية معالجة مستوى الكوليسترول العالي (حمض النيكوتينيك).</li><li style="direction: rtl;">أدوية علاج الإمساك عند إستخدامها على المدى الطويل (المسهلات).</li><li style="direction: rtl;">أدوية علاج النوبات (الفينيتوين).</li><li style="direction: rtl;">أدوية علاج العصبية ومشاكل النوم (الباربيتورات).</li><li style="direction: rtl;">أدوية علاج زيادة الضغط على العين (أزيتازولاميد).</li><li style="direction: rtl;">أدوية علاج إرتفاع ضغط الدم أو خفض نسبة السكر في الدم (ديازوكسيد).</li><li style="direction: rtl;">أدوية علاج العدوى، السل (ريفامبيسين).</li><li style="direction: rtl;">أدوية علاج إنخفاض مستويات السكر في الدم (الجلوكاجون).</li></ul><p style="direction: rtl;"><strong>قد تزيد أو تخفض الأدوية التالية من تأثير چلوريون على خفض نسبة السكر في الدم:</strong></p><ul><li style="direction: rtl;">أدوية علاج قرحة المعدة (تدعى مضادات أتش 2).</li><li style="direction: rtl;">أدوية علاج إرتفاع ضغط الدم أو فشل القلب مثل حاصرات بيتا، الكلونيدين، الغوانيثيدين وريزيربين. وهذه أيضاً يمكن ان تخفي علامات نقص سكر&nbsp;الدم، لذلك هناك حاجة إلى رعاية خاصة عند تناول هذه الأدوية.</li></ul><p style="direction: rtl;"><strong>قد يعمل چلوريون إما على زيادة أو إضعاف تأثيرات الأدوية التالية:</strong></p><ul><li style="direction: rtl;">أدوية تثبيط تجلط الدم (مشتقات الكومارين مثل الوارفارين).</li></ul><p style="direction: rtl;"><strong>تناول چلوريون مع الطعام والشراب</strong></p><p style="direction: rtl;">تناول الكحول قد يزيد أو يقلل من تأثير چلوريون على خفض نسبة السكر في الدم بطريقة لا يمكن التنبؤ بها.</p><p style="direction: rtl;"><strong>الحمل والرضاعة</strong></p><p style="direction: rtl;"><strong>الحمل</strong></p><p style="direction: rtl;">لا ينبغي تناول چلوريون أثناء الحمل. يرجى إستشارة طبيبك إذا كنت حاملاً أوتعتقدين أنك حاملاً أو تخططين لذلك.</p><p style="direction: rtl;"><strong>الرضاعة</strong></p><p style="direction: rtl;">قد ينتقل چلوريون إلى حليب الثدي. لا يجب تناول چلوريون أثناء الرضاعة.</p><p style="direction: rtl;">يرجى إستشارة طبيبك أو الصيدلي قبل تناول أي دواء.</p><p style="direction: rtl;"><strong>تأثير چلوريون على القيادة واستخدام الآلات</strong></p><p style="direction: rtl;">قد تنخفض قدرتك على التركيز أو الإستجابة إذا انخفضت نسبة السكر في الدم (نقص سكر الدم) أو إرتفعت (فرط سكر الدم) أو إذا حدثت لديك مشاكل بصرية نتيجة لهذه الظروف. وضع في اعتبارك أنك قد تعرض نفسك والآخرين للخطر (مثلاً عند قيادة السيارة أو إستخدام الآلات). يرجى مراجعة طبيبك حول إمكانية قيادة السيارة:</p><ul><li style="direction: rtl;">إذا كنت تعاني من نوبات متكررة من نقص سكر الدم.</li><li style="direction: rtl;">إذا كان لديك علامات إنذار أقل أو انعدام وجود العلامات في حالة نقص سكر الدم.</li></ul><p style="direction: rtl;"><strong>معلومات هامة حول بعض مكونات چلوريون</strong></p><p style="direction: rtl;">يحتوي چلوريون على اللاكتوز. إذا أخبرك طبيبك أنك لا تستطيع تحمل بعض السكريات، إتصل بطبيبك قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">&nbsp;يرجى إستشارة الطبيب أو الصيدلي إذا كنت غير متأكداً.</p><p style="direction: rtl;"><strong>تناول هذا الدواء</strong></p><p style="direction: rtl;">تناول هذا الدواء عن طريق الفم، مباشرة قبل أو مع وجبة الطعام الأولى الرئيسية خلال اليوم (عادةً الإفطار). إذا كنت لا تتناول وجبة الإفطار يجب أن تأخذ الدواء في الموعد الذي يحدده طبيبك. من المهم أن لا تترك أي وجبة طعام عندما تأخذ چلوريون.</p><p style="direction: rtl;">إبتلع الأقراص بأكملها مع نصف كوب من الماء على الأقل. لا تسحق أو تمضغ الأقراص.</p><p style="direction: rtl;"><strong>الكمية التي يجب تناولها</strong></p><p style="direction: rtl;">تعتمد جرعة چلوريون على حاجتك، وضعك ونتائج فحوصات السكر في الدم والبول ويتم تحديدها من قبل الطبيب. لا تاخذ أقراص أكثر مما وصفه الطبيب.جرعة البدء الإعتيادية هي قرص واحد 1 ملغم من چلوريون مرة واحدة يومياً.</p><p style="direction: rtl;">قد يقوم طبيبك عند الضرورة بزيادة الجرعة بعد كل أسبوع أو أسبوعان من العلاج.</p><p style="direction: rtl;">الجرعة القصوى الموصى بها هي 6 ملغم من الچليمبيرايد يومياً.</p><p style="direction: rtl;">يمكن البدء بالجمع بين العلاج بالچليمبيرايد والميتفورمين أو الچليمبيرايد والإنسولين. في تلك الحالة فإن طبيبك سوف يحدد لك الجرعة المناسبة من الچليمبيرايد، الميتفورمين أو الإنسولين على إنفراد.</p><p style="direction: rtl;">قد يكون هناك حاجة لتعديل جرعة الچلوريون إذا تغير وزنك أو نمط حياتك، أو إذا كنت تعاني من إجهاد شديد. يرجى مراجعة طبيبك إذا كانت أي من هذه الحالات تنطبق عليك.</p><p style="direction: rtl;">إذا كنت تشعر أن تأثير الدواء ضعيف جداً أو قوي جداً لا تغير الجرعة بنفسك بل راجع الطبيب.</p><p style="direction: rtl;"><strong>الجرعة الزائدة من چلوريون</strong></p><p style="direction: rtl;">إذا حصل وأن تناولت كمية كبيرة من الچلوريون أو جرعة إضافية فإنك معرض لخطر نقص سكر الدم (علامات نقص سكر الدم في القسم 2 &ndash; الإحتياطات عند إستخدام چلوريون) لذلك يجب ان تستهلك فوراً كمية كافية من السكر (مثلا شريط صغير من مكعبات السكر، عصير حلو، شاي محلى) وأخبر الطبيب فوراً.</p><p style="direction: rtl;">عند علاج نقص سكر الدم بسبب التناول العرضي للأطفال، فإن كمية السكر المعطاة يجب السيطرة عليها بعناية حتى يتم تجنب إمكانية فرط سكر الدم الخطير. ولا ينبغي إعطاء الأشخاص الذين في حالة فقدان الوعي أي طعام أو شراب.</p><p style="direction: rtl;">بما أن حالة نقص سكر الدم قد تستمر لفترة من الوقت فإنه من المهم مراقبة المريض بعناية حتى يزول الخطر. قد يكون الإدخال إلى المستشفى ضرورياً أيضاً كتدبير إحتياطي. دع الطبيب يرى العبوة أو الأقراص المتبقية حتى يعرف ما تم تناوله.</p><p style="direction: rtl;">الحالات الشديدة من نقص سكر الدم المصحوبة بفقدان الوعي والغيبوبة هي حالات طبية طارئة تتطلب علاج طبي فوري وإدخال إلى المستشفى. قد يكون من المفيد ان تخبر عائلتك وأصدقاءك للإتصال بالطبيب فوراً إذا حدث لك ذلك.</p><p style="direction: rtl;"><strong>نسيان تناول جرعة&nbsp;چلوريون</strong></p><p style="direction: rtl;">إذا نسيت أخذ جرعة، لا تأخذ جرعة مضاعفة حتى تعوض الجرعات التي نسيتها.</p><p style="direction: rtl;"><strong>التوقف عن استخدام چلوريون</strong></p><p style="direction: rtl;">إذا كنت تأخذ الدواء بشكل متقطع أو توقفت عن العلاج يجب أن تكون على علم بأن أثر خفض نسبة السكر في الدم المطلوب لم يتحقق أو أن المرض سيزداد سوءاً مرة اخرى. إستمر في تناول چلوريون حتى يخبرك طبيبك بأن تتوقف.</p><p style="direction: rtl;"><strong>للاستفسار أو المزيد من المعلومات عن إستخدام هذا الدواء، يرجى إستشارة الطبيب أو الصيدلي.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">مثل جميع الأدوية، قد يسبب چلوريون أعراض جانبية على الرغم من أنه ليس كل شخص يحصل له ذلك.</p><p style="direction: rtl;"><strong>أخبر طبيبك فوراً إذا واجهتك أي من الأعراض التالية:</strong></p><ul><li style="direction: rtl;">ردود فعل تحسسية (بما في ذلك التهاب الأوعية الدموية، غالباً مع طفح جلدي) والتي قد تتطور إلى ردود فعل خطرة مع صعوبة في التنفس، هبوط في&nbsp;ضغط الدم وأحياناً يتطور إلى صدمة.</li><li style="direction: rtl;">وظائف الكبد الغير طبيعية بما في ذلك إصفرار الجلد والعينين (اليرقان)، مشاكل في التفق الصفراوي (الركود الصفراوي)، التهاب الكبد (التهاب&nbsp;الكبد الوبائي) أو فشل الكبد.</li><li style="direction: rtl;">حساسية (فرط حساسية) الجلد مثل الحكة، الطفح، الشرى وزيادة الحساسية للشمس.</li><li style="direction: rtl;">بعض ردود الفعل التحسسية الخفيفة قد تتطور إلى ردود فعل خطيرة.&nbsp;</li><li style="direction: rtl;">نقص سكر الدم الشديد بما في ذلك فقدان الوعي، التشنجات أو الغيبوبة.</li></ul><p style="direction: rtl;"><strong>قد يواجه بعض المرضى الأعراض الجانبية التالية أثناء تناولهم لچلوريون:</strong></p><p style="direction: rtl;"><strong>أعراض جانبية نادرة (تؤثر على 1 إلى 10 مرضى لكل 10,000):</strong></p><ul><li style="direction: rtl;">نسبة السكر في الدم أقل من المستوى الطبيعي (نقص سكر الدم).</li><li style="direction: rtl;">انخفاض في عدد خلايا الدم:</li><li style="direction: rtl;">الصفائح الدموية (مما يزيد من خطر النزف أو الكدمات).</li><li style="direction: rtl;">خلايا الدم البيضاء (مما يجعل العدوى أكثر إحتمالاً).</li><li style="direction: rtl;">خلايا الدم الحمراء (مما قد يجعل الجلد شاحباً ويسبب الضعف أوضيق التنفس).</li></ul><p style="direction: rtl;">هذه المشاكل بشكل عام سوف تتحسن بعد التوقف عن أخذ چلوريون.</p><p style="direction: rtl;"><strong>أعراض جانبية نادرة جداً (تؤثر على أقل من مريض 1 لكل 10,000)</strong>:</p><ul><li style="direction: rtl;">ردود فعل تحسسية (بما في ذلك التهاب الأوعية الدموية، غالباً مع طفح جلدي) والتي قد تتطور إلى ردود فعل خطرة مع صعوبة في التنفس، هبوط في&nbsp;ضغط الدم وأحياناً يتقدم إلى صدمة. إذا واجهتك أي من هذه الأعراض أخبر طبيبك فوراً.</li><li style="direction: rtl;">وظائف الكبد غير الطبيعية بما في ذلك إصفرار البشرة والعينين (اليرقان)، ضعف التدفق الصفراوي (الركود الصفراوي)، التهاب الكبد (التهاب الكبد&nbsp;الوبائي) أو فشل الكبد. إذا واجهتك أي من هذه الأعراض أخبر طبيبك فوراً.</li><li style="direction: rtl;">الشعور أو الإصابة بالإعياء، الإسهال، الشعور بالإنتفاخ وألم في البطن.</li><li style="direction: rtl;">انخفاض في مستوى الصوديوم في الدم (يظهر عن طريق فحوصات الدم).</li></ul><p style="direction: rtl;"><strong>أعراض جانبية اخرى تتضمن:</strong></p><ul><li style="direction: rtl;">قد تحدث حساسية (فرط حساسية) في الجلد مثل الحكة، الطفح، الشرى وزيادة الحساسية للشمس. وقد تتطور بعض ردود الفعل التحسسية&nbsp;الخفيفة لردود فعل خطيرة في البلع أو مشاكل في التنفس، تورم الشفتين، الحلق أو اللسان. لذلك في حالة حدوث أي من هذه الأعراض الجانبية أخبر طبيبك فوراً.</li><li style="direction: rtl;">قد تحدث ردود فعل تحسسية مع السلفونيل يوريا، السلفوناميدات أو العقاقير ذات الصلة.</li><li style="direction: rtl;">قد تحدث مشاكل في النظر عند بدء العلاج بچلوريون. وهذا ناتج عن التغيرات في مستويات السكر في الدم وسوف يتحسن قريباً.</li><li style="direction: rtl;">زيادة إنزيمات الكبد.</li></ul><p style="direction: rtl;"><strong>راجع طبيبك أو الصيدلي إذا ساءت أية من هذه الآثار الجانبية أو لاحظت ظهور أية آثار جانبية غير مدرجة في هذه النشرة.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li style="direction: rtl;">إحفظ هذا الدواء بعيدا عن مرأى ومتناول الأطفال.</li><li style="direction: rtl;">لا تستخدم چلوريون بعد تاريخ انتهاء الصلاحية المذكور على العلبة الخارجية. يشير تاريخ الإنتهاء إلى اليوم الأخير من ذلك الشهر.</li><li style="direction: rtl;">لا يحفظ فوق 30&deg; مئوية.</li><li style="direction: rtl;">إحفظ الدواء في العلبة الأصلية حتى تحمية من الرطوبة.</li><li style="direction: rtl;">لا تستخدم چلوريون إذا لاحظت علامات تلف واضحة عليه.</li><li style="direction: rtl;">لا تتخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة اليها.&nbsp;هذه التدابير سوف تساعد على حماية البيئة.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">المادة الفعالة هي الچليمبيرايد. كل قرص يحتوي على 1 ملغم، 2 ملغم، 3 ملغم أو 4 ملغم چليمبيرايد إعتماداً على القوة المشار اليها على النفطة والعلبة. المواد الأخرى المستخدمة في التركيبة التصنيعية هي مونوهيدرات اللاكتوز، غليكولات نشا الصوديوم، ستيرات المغنيسيوم، سيليلوز الميكروكريستالين، وكبريتات لوريل الصوديوم.</p><p style="direction: rtl;">بالإضافة إلى أن الأقراص تحتوي على مواد التلوين التالية:</p><ul><li style="direction: rtl;">أقراص 1 ملغم تحتوي على أكسيد الحديد الأحمر.</li><li style="direction: rtl;">أقراص 2 ملغم تحتوي على أكسيد الحديد الأصفر و 12196 أف دي وبلو ليك رقم 2.</li><li style="direction: rtl;">أقراص 3 ملغم تحتوي على أكسيد الحديد الأصفر.</li><li style="direction: rtl;">أقراص 4 ملغم تحتوي على 12196 أف دي وبلو ليك رقم 2.</li></ul>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            كل قوة من چلوريون هي أقراص صغيرة مشطورة على شكل كبسولة. وكل قوة تختلف من حيث اللون والنقشة:
• أقراص 1 ملغم وردي، منقوش عليه ”H85 ”. 
• أقراص 2 ملغم أخضر، منقوش عليه  ”H84 ”.
• أقراص 3 ملغم أصفر، منقوش عليه ”H83 ”.
• أقراص 4 ملغم أزرق، منقوش عليه ”H82 ”. 

        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;"><strong>اسم وعنوان مالك رخصة التسويق والشركة المصنعة</strong></p><p style="direction: rtl;">شركة أدوية الحكمة</p><p style="direction: rtl;">بيادر وادي السير، المدينة الصناعية</p><p style="direction: rtl;">صندوق بريد 182400</p><p style="direction: rtl;">عمان 11118، الأردن</p><p style="direction: rtl;">هاتف:&nbsp;&nbsp;96265802900 +</p><p style="direction: rtl;">فاكس:&nbsp;&nbsp;96265817102 +</p><p style="direction: rtl;">الموقع الإلكتروني:&nbsp;&nbsp;www.Hikma.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقة على هذه النشرة بتاريخ 2013/11، رقم النسخة 1.1.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Glorion® 3 mg Tablet


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 3 mg glimepiride.

It also contains 111 mg lactose monohydrate per tablet. 

For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Yellow small bisected capsule shape tablets engraved with H83.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glorion is indicated for the treatment of type 2 diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For oral administration.</p><p>&nbsp;</p><p>The basis for successful treatment of diabetes is a good diet, regular physical activity, as well as routine checks of blood and urine. Tablets or insulin cannot compensate if the patient does not keep to the recommended diet.</p><p>&nbsp;</p><p>Dosage is determined by the results of blood and urinary glucose determinations.</p><p>&nbsp;</p><p>The starting dose is 1 mg glimepiride per day. If good control is achieved this dosage should be used for maintenance therapy.</p><p>&nbsp;</p><p>For the different dosage regimens appropriate strengths are available.</p><p>&nbsp;</p><p>If control is unsatisfactory the dosage should be increased, based on the glycaemic control, in a stepwise manner with an interval of about 1 to 2 weeks between each step, to 2, 3 or 4 mg glimepiride per day.</p><p>&nbsp;</p><p>A dosage of more than 4 mg glimepiride per day gives better results only in exceptional cases. The maximum recommended dose is 6 mg glimepiride per day.</p><p>&nbsp;</p><p>In patients not adequately controlled with the maximum daily dose of metformin, concomitant glimepiride therapy can be initiated.</p><p>&nbsp;</p><p>While maintaining the metformin dose, the glimepiride therapy is started with a low dose, and is then titrated up depending on the desired level of metabolic control up to the maximum daily dose. The combination therapy should be initiated under close medical supervision.</p><p>&nbsp;</p><p>In patients not adequately controlled with the maximum daily dose of Glorion, concomitant insulin therapy can be initiated if necessary. While maintaining the glimepiride dose, insulin treatment is started at low dose and titrated up depending on the desired level of &nbsp;metabolic&nbsp; control. The &nbsp;combination &nbsp;therapy should &nbsp;be &nbsp;initiated under close medical supervision.</p><p>&nbsp;</p><p>Normally a single daily dose of glimepiride is sufficient. It is recommended that this dose be taken shortly before or during a substantial breakfast or - if none is taken - shortly before or during the first main meal.</p><p>&nbsp;</p><p>If a dose is forgotten, this should not be corrected by increasing the next dose.</p><p>&nbsp;</p><p>Tablets should be swallowed whole with some liquid.</p><p>&nbsp;</p><p>If a patient has a hypoglycaemic reaction on 1 mg glimepiride daily, this indicates that they can be controlled by diet alone.</p><p>&nbsp;</p><p>In the course of treatment, as an improvement in control of diabetes is associated with higher insulin sensitivity, glimepiride requirements may fall. To avoid hypoglycaemia timely dose reduction or cessation of therapy must therefore be considered. Change in dosage may also be necessary, if there are changes in weight or life style of the patient, or other factors that increase the risk of hypo-or hyperglycaemia.</p><p>&nbsp;</p><p>Switch over from other oral hypoglycaemic agents to Glorion</p><p>A switch over from other oral hypoglycaemic agents to Glorion can generally be done. For the switch over to Glorion the strength and the half-life of the previous medicinal product has to be taken into account. In some cases, especially in antidiabetics with a long half-life (e.g. chlorpropamide), a wash out period of a few days is advisable in order to minimise the risk of hypoglycaemic reactions due to the additive effect.</p><p>&nbsp;</p><p>The recommended starting dose is 1 mg glimepiride per day. Based on the response the glimepiride dosage may be increased stepwise, as indicated earlier.</p><p>&nbsp;</p><p>Switch over from Insulin to Glorion</p><p>In &nbsp;exceptional &nbsp;cases, &nbsp;where &nbsp;type &nbsp;2 &nbsp;diabetic &nbsp;patients &nbsp;are &nbsp;regulated &nbsp;on &nbsp;insulin, &nbsp;a changeover to Glorion may be indicated. The changeover should be undertaken under close medical supervision.</p><p>&nbsp;</p><ul><li>Special Populations</li></ul><p>- Patients with renal or hepatic impairment.&nbsp;See section 4.3.</p><p>&nbsp;</p><p>- Pediatric population</p><p>There are no data available on the use of glimepiride in patients under 8 years of age. For children aged 8 to 17 years, there are limited data on glimepiride as monotherapy (see sections 5.1 and 5.2).</p><p>&nbsp;</p><p>The available data on safety and efficacy are insufficient in the paediatric population and therefore such use is not recommended.</p><p>&nbsp;</p><ul><li><u>M</u><u>ethod of administration</u></li></ul><p>Tablets should be swallowed without chewing with some liquid.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Glimepiride is contraindicated in patients with the following conditions:
•  Hypersensitivity to glimepiride, other sulfonylureas or sulfonamides or to any of the excipients
•  Insulin dependent diabetes,
•  Diabetic coma,
•  Ketoacidosis,
•  Severe renal or hepatic function disorders. In case of severe renal or hepatic function disorders, a changeover to insulin is required.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glorion must be taken shortly before or during a meal.</p><p>&nbsp;</p><p>When meals are taken at irregular hours or skipped altogether, treatment with Glorion may lead to hypoglycaemia. Possible symptoms of hypoglycaemia include: headache, ravenous hunger, nausea, vomiting, lassitude, sleepiness, disordered sleep, restlessness, aggressiveness, impaired concentration, alertness and reaction time, depression, confusion, speech and visual disorders, aphasia, tremor, paresis, sensory disturbances, dizziness, helplessness, loss of self-control, delirium, cerebral convulsions, somnolence and loss of consciousness up to and including coma, shallow respiration and bradycardia. In addition, signs of adrenergic counter-regulation may be present such as sweating, clammy skin, anxiety, tachycardia, hypertension, palpitations, angina pectoris and cardiac arrhythmias.</p><p>&nbsp;</p><p>The clinical picture of a severe hypoglycaemic attack may resemble that of a stroke.</p><p>&nbsp;</p><p>Symptoms can almost always be promptly controlled by immediate intake carbohydrates (sugar). Artificial sweeteners have no effect.</p><p>&nbsp;</p><p>It is known from other sulfonylureas that, despite initially successful countermeasures, hypoglycaemia may recur.</p><p>&nbsp;</p><p>Severe hypoglycaemia or prolonged hypoglycaemia, only temporarily controlled by the usual amounts of sugar, require immediate medical treatment and occasionally hospitalisation.</p><p>&nbsp;</p><p>Factors favouring hypoglycaemia include:</p><p>- &nbsp;unwillingness &nbsp;or &nbsp;(more &nbsp;commonly &nbsp;in &nbsp;older &nbsp;patients) &nbsp;incapacity &nbsp;of &nbsp;the &nbsp;patient &nbsp;to cooperate,</p><p>- undernutrition, irregular mealtimes or missed meals or periods of fasting,</p><p>- alterations in diet,</p><p>- imbalance between physical exertion and carbohydrate intake,</p><p>- consumption of alcohol, especially in combination with skipped meals,</p><p>- impaired renal function,</p><p>- serious liver dysfunction,</p><p>- overdosage with Glorion,</p><p>- certain uncompensated disorders of the endocrine system affecting carbohydrate metabolism or counter-regulation of hypoglycaemia (as for example in certain disorders of thyroid function and in anterior pituitary or adrenocortical insufficiency),</p><p>- concurrent administration of certain other medicinal products (see section 4.5).</p><p>&nbsp;</p><p>Treatment with Glorion requires regular monitoring of glucose levels in blood and urine.</p><p>&nbsp;</p><p>In&nbsp;addition&nbsp;determination&nbsp;of&nbsp;the&nbsp;proportion&nbsp;of&nbsp;glycosylated&nbsp;haemoglobin&nbsp;is recommended.</p><p>&nbsp;</p><p>Regular hepatic and haematological monitoring (especially leucocytes and thrombocytes) are required during treatment with Glorion.</p><p>&nbsp;</p><p>In &nbsp;stress-situations &nbsp;(e.g. &nbsp;accidents, &nbsp;acute &nbsp;operations, &nbsp;infections &nbsp;with &nbsp;fever, &nbsp;etc.) &nbsp;a temporary switch to insulin may be indicated.</p><p>&nbsp;</p><p>No experience has been gained concerning the use of Glorion in patients with severe impairment of liver function or dialysis patients. In patients with severe impairment of renal or liver function change over to insulin is indicated.</p><p>&nbsp;</p><p>Treatment of patients with G6PD-deficiency with sulfonylurea agents can lead to hemolytic anaemia. Since glimepiride belongs to the class of sulfonylurea agents, caution should be used in patients with G6PD-deficiency and a non-sulfonylurea alternative should be considered.</p><p>&nbsp;</p><p>Glorion contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>If glimepiride is taken simultaneously with certain other medicinal products, both undesired increases and decreases in the hypoglycaemic action of glimepiride can occur. For this reason, other medicinal products should only be taken with the knowledge (or at the prescription) of the doctor.</p><p>&nbsp;</p><p>Glimepiride is metabolized by cytochrome P450 2C9 (CYP2C9). Its metabolism is known to be influenced by concomitant administration of CYP2C9 inducers (e.g. rifampicin) or inhibitors (e.g. fluconazole).</p><p>&nbsp;</p><p>Results from an in vivo interaction study reported in literature show that glimepiride AUC is increased approximately 2-fold by fluconazole, one of the most potent CYP2C9 inhibitors.</p><p>&nbsp;</p><p>Based on the experience with glimepiride and with other sulfonylureas the following interactions have to be mentioned.</p><p>&nbsp;</p><p>Potentiation of the blood-glucose-lowering effect and, thus, in some instances hypoglycaemia may occur when one of the following medicinal products is taken, for example:</p><p>- phenylbutazone, azapropazone and oxyfenbutazone,</p><p>- insulin and oral antidiabetic products, such as metformin, - salicylates and p-amino- salicylic acid,</p><p>- anabolic steroids and male sex hormones,</p><p>- chloramphenicol, certain long acting sulfonamides, tetracyclines, quinolone antibiotics and clarithromycin</p><p>- coumarin anticoagulants,</p><p>- fenfluramine,</p><p>- disopyramide,</p><p>- fibrates,</p><p>- ACE inhibitors,</p><p>- fluoxetine, MAO-inhibitors</p><p>- allopurinol, probenecid, sulfinpyrazone,</p><p>- sympatholytics,</p><p>- cyclophosphamide, trophosphamide and iphosphamides,</p><p>- miconazole, fluconazole</p><p>- pentoxifylline (high dose parenteral),</p><p>- tritoqualine</p><p>&nbsp;</p><p>Weakening of the blood-glucose-lowering effect and, thus raised blood glucose levels may occur when one of the following medicinal products is taken, for example:</p><p>- oestrogens and progestogens,</p><p>- saluretics, thiazide diuretics,</p><p>- thyroid stimulating agents, glucocorticoids,</p><p>- phenothiazine derivatives, chlorpromazine,</p><p>- adrenaline and sympathicomimetics,</p><p>- nicotinic acid (high dosages) and nicotinic acid derivatives,</p><p>- laxatives (long term use),</p><p>- phenytoin, diazoxide,</p><p>- glucagon, barbiturates and rifampicin,</p><p>- acetazolamide.</p><p>&nbsp;</p><p>H<sub>2</sub> antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of the blood glucose lowering effect.</p><p>&nbsp;</p><p>Under &nbsp;the &nbsp;influence &nbsp;of&nbsp; &nbsp;sympatholytic &nbsp;medicinal &nbsp;products &nbsp;such &nbsp;as &nbsp;beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation to hypoglycaemia may be reduced or absent.</p><p>&nbsp;</p><p>Alcohol intake may potentiate or weaken the hypoglycaemic action of glimepiride in an unpredictable fashion.</p><p>&nbsp;</p><p>Glimepiride may either potentiate or weaken the effects of coumarin derivatives.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Pregnancy</li></ul><p>&nbsp;</p><p>- Risk related to the diabetes</p><p>Abnormal blood glucose levels during pregnancy are associated with a higher incidence of congenital abnormalities and perinatal mortality. So the blood glucose level must be closely monitored during pregnancy in order to avoid the teratogenic risk. The use of insulin is required under such circumstances. Patients who consider pregnancy should inform their physician.</p><p>&nbsp;</p><p>- Risk related to glimepiride</p><p>There are no adequate data from the use of glimepiride in pregnant women. Animal studies have shown reproductive toxicity which likely was related to the pharmacologic action (hypoglycaemia) of glimepiride (see section 5.3).</p><p>&nbsp;</p><p>Consequently, glimepiride should not be used during the whole pregnancy.</p><p>&nbsp;</p><p>In case of treatment by glimepiride, if the patient plans to become pregnant or if a pregnancy is discovered, the treatment should be switched as soon as possible to insulin therapy.</p><p>&nbsp;</p><ul><li>Lactation</li></ul><p>The excretion in human milk is unknown. Glimepiride is excreted in rat milk. As other sulfonylureas are excreted in human milk and because there is a risk of hypoglycaemia in nursing infants, breast-feeding is advised against during treatment with glimepiride.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed.</p><p>&nbsp;</p><p>The patient&#39;s ability to concentrate and react may be impaired as a result of hypoglycaemia or hyperglycaemia or, for example, as a result of visual impairment. This may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery).</p><p>&nbsp;</p><p>Patients should be advised to take precautions to avoid hypoglycaemia whilst driving. This is particularly important in those who have reduced or absent awareness of the warning symptoms of hypoglycaemia or have frequent episodes of hypoglycaemia. It should be considered whether it is advisable to drive or operate machinery in these circumstances.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions from clinical investigations were based on experience with Glorion and other sulfonylureas, were listed below by system organ class and in order of decreasing incidence (very common: &ge;1/10; common: &ge;1/100 to &lt;1/10; uncommon: &ge;1/1,000 to &lt;1/100; rare: &ge;1/10,000 to &lt;1/1,000; very rare: &lt;1/10,000), not known (cannot be estimated from the available data).</p><p>&nbsp;</p><p><strong>Blood and lymphatic system disorders</strong></p><p>Rare: thrombocytopenia, leukopenia, granulocytopenia, agranulocytosis, erythropenia, haemolytic anaemia and pancytopenia, which are in general reversible upon discontinuation of medication.</p><p>&nbsp;</p><p><strong>I</strong><strong>mm</strong><strong>un</strong><strong>e system disorders</strong></p><p>Very rare: leukocytoclastic vasculitis, mild hypersensitivity reactions that may develop into serious reactions with dyspnoea, fall in blood pressure and sometimes shock.</p><p>Not-known: cross-allergenicity with sulfonylureas, sulfonamides or related substances is possible.</p><p>&nbsp;</p><p><strong>Me</strong><strong>tabolism and nutrition disorders</strong></p><p>Rare: hypoglycaemia.</p><p>These hypoglycaemic reactions mostly occur immediately, may be severe and are not always easy to correct. The occurrence of such reactions depends, as with other hypoglycaemic therapies, on individual factors such as dietary habits and dosage (see further under section 4.4).</p><p>&nbsp;</p><p><strong>Eye disorders</strong></p><p>Not &nbsp;known: &nbsp;visual &nbsp;disturbances, &nbsp;transient, &nbsp;may &nbsp;occur &nbsp;especially &nbsp;on &nbsp;initiation &nbsp;of treatment, due to changes in blood glucose levels.</p><p>&nbsp;</p><p><strong>Gastrointestinal disorders</strong></p><p>Very rare: nausea, vomiting, diarrhoea, abdominal distension, abdominal discomfort and abdominal pain, which seldom lead to discontinuation of therapy.</p><p>&nbsp;</p><p><strong>Hepato-biliary disorders</strong></p><p>Not know: hepatic enzymes increased.</p><p>Very rare: hepatic function abnormal (e.g. with cholestasis and jaundice), hepatitis and hepatic failure.</p><p>&nbsp;</p><p><strong>Skin and subcutaneous tissue disorders</strong></p><p>Not known: hypersensitivity reactions of the skin may occur as pruritus, rash, urticaria and photosensitivity.</p><p>&nbsp;</p><p><strong>In</strong><strong>vestigations</strong></p><p>Very rare: blood sodium decrease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After ingestion of an overdosage hypoglycaemia may occur, lasting from 12 to 72 hours, and may recur after an initial recovery. Symptoms may not be present for up to 24 hours after ingestion. In general observation in hospital is recommended. Nausea, vomiting and epigastric pain may occur. The hypoglycaemia may in general be accompanied by neurological symptoms like restlessness, tremor, visual disturbances, co-ordination problems, sleepiness, coma and convulsions.</p><p>&nbsp;</p><p>Treatment primarily consists of preventing absorption by inducing vomiting and then drinking water or lemonade with activated charcoal (adsorbent) and sodium-sulphate (laxative). If large quantities have been ingested, gastric lavage is indicated, followed by activated charcoal and sodium-sulphate. In case of (severe) overdosage hospitalisation in an intensive care department is indicated. Start the administration of glucose as soon as possible, &nbsp;if necessary&nbsp;by &nbsp;a&nbsp;bolus intravenous injection of 50 ml&nbsp;of &nbsp;a&nbsp;50% &nbsp;solution, followed by an infusion of a 10% solution with strict monitoring of blood glucose. Further treatment should be symptomatic.</p><p>&nbsp;</p><p>In particular when treating hypoglycaemia due to accidental intake of Glorion in infants and young children, the dose of glucose given must be carefully controlled to avoid the possibility of producing dangerous hyperglycaemia. Blood glucose should be closely monitored.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Blood glucose lowering drugs, excl. insulins: Sulfonamides, urea derivatives.</p><ul><li>ATC Code: A10B B12.</li></ul><p>&nbsp;</p><p>Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.</p><p>&nbsp;</p><p>Glimepiride acts mainly by stimulating insulin release from pancreatic beta cells.</p><p>&nbsp;</p><p>As with other sulfonylureas this effect is based on an increase of responsiveness of the pancreatic beta cells to the physiological glucose stimulus. In addition, glimepiride seems to have pronounced extrapancreatic effects also postulated for other sulfonylureas.</p><p>&nbsp;</p><ul><li>Insulin release</li></ul><p>Sulfonylureas regulate insulin secretion by closing the ATP-sensitive potassium channel in the beta cell membrane. Closing the potassium channel induces depolarisation of the beta cell and results - by opening of calcium channels - in an increased influx of calcium into the cell.</p><p>&nbsp;</p><p>This leads to insulin release through exocytosis.</p><p>&nbsp;</p><p>Glimepiride binds with a high exchange rate to a beta cell membrane protein which is associated with the ATP-sensitive potassium channel but which is different from the usual sulfonylurea binding site.</p><p>&nbsp;</p><ul><li>Extrapancreatic activity</li></ul><p>The extrapancreatic effects are for example an improvement of the sensitivity of the peripheral tissue for insulin and a decrease of the insulin uptake by the liver.</p><p>&nbsp;</p><p>The uptake of &nbsp;glucose from blood &nbsp;into peripheral muscle and &nbsp;fat tissues occurs via special transport proteins, located in the cells membrane. The transport of glucose in these tissues is the rate limiting step in the use of glucose. Glimepiride increases very rapidly the number of active glucose transport molecules in the plasma membranes of muscle and fat cells, resulting in stimulated glucose uptake.</p><p>&nbsp;</p><p>Glimepiride increases the activity of the glycosyl-phosphatidylinositol-specific phospholipase C which may be correlated with the drug-induced lipogenesis and glycogenesis in isolated fat and muscle cells.</p><p>&nbsp;</p><p>Glimepiride inhibits the glucose production in the liver by increasing the intracellular concentration of fructose-2, 6-bisphosphate, which in its turn inhibits the gluconeogenesis.</p><p>&nbsp;</p><ul><li>General</li></ul><p>In healthy persons, the minimum effective oral dose is approximately 0.6 mg. The effect of glimepiride is dose-dependent and reproducible. The physiological response to acute physical exercise, reduction of insulin secretion, is still present under glimepiride.</p><p>&nbsp;</p><p>There was no significant difference in effect regardless of whether the medicinal product was given 30 minutes or immediately before a meal. In diabetic patients, good metabolic control over 24 hours can be achieved with a single daily dose.</p><p>&nbsp;</p><p>Although the hydroxy metabolite of glimepiride caused a small but significant decrease in serum glucose in healthy persons, it accounts for only a minor part of the total drug effect.</p><p>&nbsp;</p><ul><li>Combination therapy with metformin</li></ul><p>Improved metabolic control for concomitant glimepiride therapy compared to metformin alone in patients not adequately controlled with the maximum dosage of metformin has been shown in one study.</p><p>&nbsp;</p><ul><li>Combination therapy with insulin</li></ul><p>Data for combination therapy with insulin are limited. In patients not adequately controlled with the maximum dosage of glimepiride, concomitant insulin therapy can be initiated. In two studies, the combination achieved the same improvement in metabolic control as insulin alone; however, a lower average dose of insulin was required in combination therapy.</p><p>&nbsp;</p><ul><li>Special populations</li></ul><p>- Pediatric population</p><p>An active controlled clinical trial (glimepiride up to 8 mg daily or metformin up to 2,000 mg daily) of 24 weeks duration was performed in 285 children (8-17 years of age) with type 2 diabetes.</p><p>&nbsp;</p><p>Both &nbsp;glimepiride &nbsp;and &nbsp;metformin &nbsp;exhibited &nbsp;a &nbsp;significant &nbsp;decrease &nbsp;from &nbsp;baseline &nbsp;in HbA<sub>1c </sub>(glimepiride -0.95 (se 0.41); metformin -1.39 (se 0.40)). However, glimepiride did not achieve the criteria of non-inferiority to metformin in mean change from baseline of HbA<sub>1c</sub>. The difference between treatments was 0.44% in favour of metformin. The upper limit (1.05) of the 95% confidence interval for the difference was not below the 0.3% non-inferiority margin.</p><p>&nbsp;</p><p>Following glimepiride treatment, there were no new safety concerns noted in children compared to adult patients with type 2 diabetes mellitus. No long-term efficacy and safety data are available in paediatric patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>&nbsp;Absorption</li></ul><p>The bioavailability of glimepiride after oral administration is complete. Food intake has no &nbsp;relevant &nbsp;influence &nbsp;on &nbsp;absorption, &nbsp;only &nbsp;absorption &nbsp;rate &nbsp;is &nbsp;slightly &nbsp;diminished. Maximum serum concentrations (C<sub>max</sub>) are reached approx. 2.5 hours after oral intake (mean 0.3 &micro;g/ml during multiple dosing of 4 mg daily) and there is a linear relationship between dose and both C<sub>max</sub> and AUC (area under the time/concentration curve).</p><p>&nbsp;</p><ul><li>Distribution</li></ul><p>Glimepiride has a very low distribution volume (approx. 8.8 litres) which is roughly equal to the albumin distribution space, high protein binding (&gt;99%), and a low clearance (approx. 48 ml/min).</p><p>&nbsp;</p><p>In animals, glimepiride is excreted in milk. Glimepiride is transferred to the placenta. Passage of the blood brain barrier is low.</p><p>&nbsp;</p><ul><li>Biotransformation and elimination</li></ul><p>Mean dominant serum half-life, which is of relevance for the serum concentrations under multiple-dose conditions, is about 5 to 8 hours. After high doses, slightly longer half-lives were noted.</p><p>&nbsp;</p><p>After a single dose of radiolabelled glimepiride, 58% of the radioactivity was recovered in the urine, and 35% in the faeces. No unchanged substance was detected in the urine. Two metabolites - most probably resulting from hepatic metabolism (major enzyme is CYP2C9) - &nbsp;were identified both &nbsp;in &nbsp;urine &nbsp;and faeces: the hydroxy derivative and &nbsp;the carboxy derivative. After oral administration of glimepiride, the terminal half-lives of these metabolites were 3 to 6 and 5 to 6 hours respectively.</p><p>&nbsp;</p><p>Comparison of single and multiple once-daily dosing revealed no significant differences in pharmacokinetics, and the intraindividual variability was very low. There was no relevant accumulation.</p><p>&nbsp;</p><ul><li>Special populations</li></ul><p>Pharmacokinetics were similar in males and females, as well as in young and elderly (above &nbsp;65 &nbsp;years)&nbsp; patients. &nbsp;In patients with low creatinine clearance, &nbsp;there &nbsp;was &nbsp;a tendency for glimepiride clearance to increase and for average serum concentrations to decrease,&nbsp; most &nbsp;probably &nbsp;resulting &nbsp;from &nbsp;a &nbsp;more &nbsp;rapid &nbsp;elimination &nbsp;because &nbsp;of &nbsp;lower protein binding. Renal elimination of the two metabolites was impaired. Overall no additional risk of accumulation is to be assumed in such patients.</p><p>&nbsp;</p><p>Pharmacokinetics in five non-diabetic patients after bile duct surgery were similar to those in healthy persons.</p><p>&nbsp;</p><p>- Pediatric population</p><p>A fed study investigating the pharmacokinetics, safety, and tolerability of a 1 mg single dose of glimepiride in 30 paediatric patients (4 children aged 10-12 years and 26 children aged 12-17 years) with type 2 diabetes showed mean AUC<sub>(0-last)</sub> , C<sub>max</sub> and t<sub>1/2</sub> similar to that previously observed in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical effects observed occurred at exposures sufficiently in excess of the maximum human exposure as to indicate little relevance to clinical use, or were due to the pharmacodynamic action (hypoglycaemia) of the compound. This finding is based on conventional safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenicity, and reproduction toxicity studies. In the latter (covering embryotoxicity, teratogenicity and developmental toxicity), adverse effects observed were considered to be secondary to the hypoglycaemic effects induced by the compound in dams and in offspring.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- Lactose monohydrate</p><p>- sodium starch glycolate</p><p>- magnesium stearate</p><p>- microcrystalline cellulose</p><p>- yellow iron oxide</p><p>- sodium lauryl sulfate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blisters.</p><p>Pack size: 30 tablets.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hikma Pharmaceuticals 
Bayader Wadi El Seer 
Industrial Area
P.O Box 182400
Amman 11118, Jordan

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                25 July 2013
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>